260P - PAM50 and CGH-array genomic characterization of HER2-equivocal breast cancers defined by the 2018 ASCO/CAP recommendations. - Ngo, C.; Borcoman, E.; Rapinat, A.; Simaga, F.; Mouterfi, N.; Mariani, O.; Fuhrmann, L.; Jeannot, E.; Lae, M.; Pierga, J.-Y.; Gentien, D.; Pierron, G.; et al. (Annals of Oncology, 2019)